Newsletter | January 12, 2021

01.12.21 -- What You Need To Know To Avoid Costly Delays In Your API Scale-Up

Industry Insights
What You Need To Know To Avoid Costly Delays In Your API Scale-Up

If, in the course of the development process, undesirable effects occur that negatively impact API scale-up, it can prevent a company from delivering a product with reliable quality and efficacy. 

Can mRNA Disrupt The Biopharma Industry?

mRNA has the potential to revolutionize the field of vaccine development. However, it is critical we understand any factors that could impact its successful entry into today’s market.

Lipid Formulations To Enhance Bioavailability In Early Development

To prevent delays and costly issues during molecular development, it is important to understand potential mechanisms of increased absorption with lipid formulations and the appropriate screening tools.

The Supply Chain Executive’s Perspective On Single-Supplier CDMOs

A single vendor offers access to a network of experts who can share knowledge about a project as it moves from phase to phase, thus helping to navigate its path toward commercial success. 

Novel Analytics To Improve Bioprocessing And Validation Guideline Review

This presentation highlights how innovative protein analysis technologies have been adopted for better comparability, release testing, and impurity monitoring to improve characterization and productivity.

Process Characterization: Ready For The FDA?

Greg Sears, Ph.D., Global Director, Process Characterization, Head of Manufacturing Science & Tech, Pharma Services, Biologics at Thermo Fisher Scientific, discusses process characterization basics.

Most Popular News
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.